1-3 of 3
Michal Hlinka
Close
Sort by
Journal Articles

Improved Outcome of Patients with Invasive Pulmonary Fungal Infection Complicated by Respiratory Failure Due to the Use of New Antimycotis Agens and Early Tracheostomy after Allogeneic Transplantation.

Michael Koldehoff, MD, Ahmet H. Elmaagacli, MD, PH, Nina K. Steckel, MD, Rudolf Trenschel, MD, Michal Hlinka, Markus Ditschkowski, MD, Harald Biersack, MD, Dietrich W. Beelen, MD, PH
Journal: Blood
Blood (2005) 106 (11): 5355.
https://doi.org/10.1182/blood.V106.11.5355.5355
Published: 2005
Journal Articles

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Ahmet Elmaagacli, MD, Helmut Ottinger, MD, Micheal Flasshove, MD, Dietrich W. Beelen, MD
Journal: Blood
Blood (2004) 104 (11): 5049.
https://doi.org/10.1182/blood.V104.11.5049.5049
Published: 2004
Journal Articles

Myeloablative Treosulfan as Preparative Regimen for Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Centre Experience.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Ahmet Elmaagacli, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Rudolf Peceny, MD, Helmut Ottinger, MD, Michael Koldehoff, MD, Harry Biersack, MD, Michael Flasshove, MD, Dietrich W. Beelen, MD
Journal: Blood
Blood (2004) 104 (11): 3343.
https://doi.org/10.1182/blood.V104.11.3343.3343
Published: 2004